European Archives - Page 1097 of 1425 - European Medical Journal

Longitudinal Trend Analysis of Serum Transferrin Receptor-1 Level in a Cohort of 104 Patients Affected by Non-Transfusion-Dependent Thalassaemia

The proper management of patients with non-transfusion-dependent thalassaemia (NTDT) has been a challenging mission. In fact, NTDT encompasses a great…

Combined Oral Administration of Analgesia and Anxiolysis for Pain Associated with Bone Marrow Aspiration and Biopsy

Bone marrow aspiration and biopsy (BMAB) is a painful procedure. The commonly adopted local infiltration anaesthesia (LIA) with lidocaine is unable to…

Novel Agents for the Management of Relapsed Multiple Myeloma

Multiple myeloma (MM) is a malignant neoplasm of plasma cells that accumulate in bone marrow, leading to bone destruction and marrow failure. MM accounts…

Innovative Techniques to Reduce the Burden of Chronic Disease

An interview with Mr Teemu Suna, CEO of Nightingale Health Ltd, about Nightingale Health Ltd global efforts to combat chronic disease

An interview with Gwenan White from AbbVie

An interview with Gwenan White, UK Director of Communications, AbbVie, at Cannes Lions 2018, who discusses how pharma can work in the preventative health…

Novel Technique Could Provide More Effective Treatment for Spinal Column Tumours

Tumours in spinal columns could be treated by adapting a procedure called kyphoplasty, which is used to heal spinal fractures caused by tumours or…

Conversations with a Non-Clinical Worker Enhances End-of-Life Cancer Care

End-of-life cancer care is enhanced and costs less when patients discuss their preferences with a trained non-clinical worker soon after diagnosis…

European Medical Journal Presents: EMJ Rheumatology 5.1

The European Medical Journal has published the latest edition of EMJ Rheumatology, which includes a full review of the European League Against Rheumatism (EULAR) congress, a selection of peer-reviewed papers, interviews with members of our esteemed editorial board, and much more.

Treating Rheumatoid Arthritis to Target: Is Low Disease Activity Good Enough?

Treat-to-target principles in rheumatoid arthritis (RA) are now widely recognised as effective in achieving optimal disease outcomes. This study examined…

Anti-TNF in Rheumatic Diseases: Inventory and Outlook

With an increasing number of biosimilars receiving regulatory approval, the treatment landscape for rheumatic diseases is evolving. Healthcare…